Value Age -median (IQR) 59.1 (42.5-70.6) Sex -no (%) Male 18 (35.3) Marital Status -no (%) Married or civil union 24 (47.1) Live-in partner 13 (25.5) Single 5 (9.9) Separated 7 (13.7) Widowed 2 (3.9) Education level -no (%) Primary school Secondary school 16 (31.3) 22 (43.1) College 13 (25.6) Place of recruitment -no (%) Inpatients 13 (25.5) Outpatients 38 (74.5) No. of medications per patient -median (IQR) 3.0 (1.0-4.0)
Supplementary Table S2. Definition of patient adherence for comparison with MMAS-4 and TBQ (validation at patient level)
Example of a patient taking 5 drugs: Source language: English, target language: French Two reports of the translation were written by translators (CB and CZ) with additional comments about uncertainties.
Stage 2: preliminary synthesis
Any discrepancies with translators' reports were resolved to reach a consensus. A report was written and a preliminary questionnaire was produced by a working group (CC, SS, V-TT)
Stage 3: first pilot testing 34 patients were recruited and completed the questionnaire.
During one-to-one debriefing interviews, patients were asked about the meaning of each item to ensure good understanding. In cases of inconsistency, patients were asked to explain their answers. The investigators (SS and CC) focused on any phrases that systematically failed to elicit an appropriate answer.
A report was written (CC, SS).
Stage 4: second synthesis
A working group (CC, SS, V-TT) analyzed the report and the questionnaires. The group reworded the second and third question of Adherence Estimator to improve the clarity and adapted Lu's rating response scale to an 11-step scale, as suggested by patients. The initial planned question about generic use was removed because of misunderstanding and to reduce time needed to complete the questionnaire. A modified questionnaire was produced. Stage 5: second pilot testing 17 patients were recruited and completed the modified questionnaire. The investigators (SS and CC) used the same method as for the first pilot testing.
Stage 6: final synthesis
The final questionnaire was elaborated. Patients were asked to complete a 14-day diary for a randomly chosen drug. One investigator assessed drug adherence from data in diaries: each reported drug intake was considered a taken dose and each missing intake a missing dose; schedule errors were assessed by determining the time between reported doses. Agreement is described by the intraclass correlation coefficient (ICC). The 95% confidence intervals (95% CIs) were determined by a bootstrap method. 
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